Asked a few weeks ago by this newspaper about the medications approximate launch date in Spain, Francisco Pajuelo, Novo Nordisks medical director in Spain, declined to specify a date and commented that the drug shortages will continue throughout 2023. Sign up for our weekly newsletter to get more English-language news coverage from EL PAS USA Edition
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 3)
Experience groundbreaking advancements with our innovative compounds
April 2, 2026: More Vision Loss Lawsuits Filed There are now more than 70 GLP-1 blindness lawsuits grouped together in federal court, with others filed in state court as well
A Review of the Traditional Uses, Phytochemistry and Pharmacology of Bryophyllum pinnatum (Lam.) (Crassulaceae)
Wegovy can cost more than Ozempic , though there are ways to save, which well go through